20 assets in Transient Ischemic Attack

Therapeutic assets addressing Transient Ischemic Attack, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Aspirin Transient Ischemic Attack	Sichuan Provincial People's Hospital	P4	BBB (77)
Clopidogrel Transient Ischemic Attack	Sichuan Provincial People's Hospital	P4	BBB (77)
Cilostazol Transient Ischemic Attack	Stanford University	P4	BBB (75)
Ticagrelor Transient Ischemic Attack	Mazandaran University of Medical Sciences	P3	BBB (75)
Apixaban Transient Ischemic Attack	Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec	P4	BBB (73)
Rivaroxaban Transient Ischemic Attack	General Hospital of Shenyang Military Region	P4	BBB (73)
3-N-BUTYLPHTHALIDE Transient Ischemic Attack	Peking Union Medical College Hospital	P4	BBB (72)
Warfarin Transient Ischemic Attack	Seoul National University Hospital	P4	BB (71)
Dabigatran Transient Ischemic Attack	Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec	P4	BB (67)
Colchicinum Transient Ischemic Attack	Assistance Publique - Hôpitaux de Paris	P3	BB (66)
Atorvastatin Transient Ischemic Attack	Prof. dr. Nathalie van der Velde	P4	BB (65)
Edoxaban Transient Ischemic Attack	Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec	P4	BB (65)
Simvastatin Transient Ischemic Attack	Prof. dr. Nathalie van der Velde	P4	BB (65)
Asundexian Transient Ischemic Attack	Bayer	P3	B (62)
Fluvastatin Transient Ischemic Attack	Prof. dr. Nathalie van der Velde	P4	B (62)
Pravastatin Transient Ischemic Attack	Prof. dr. Nathalie van der Velde	P4	B (62)
Rosuvastatin Transient Ischemic Attack	Prof. dr. Nathalie van der Velde	P4	B (62)
Probucol Transient Ischemic Attack	First Affiliated Hospital of Wannan Medical College	P3	B (60)
Tirofiban Transient Ischemic Attack	Beijing Tiantan Hospital	P3	B (60)